Jinling Pharmaceutical Company Limited (000919.SZ) SHZ
Currency In CNY
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In CNY
| Market Cap | 4.94B |
| Enterprise Value | 3.61B |
| P/E Ratio | 65.68 |
| PEG Ratio | 0.42 |
| Price/Sales Ratio | 1.23 |
| Price/Book Ratio | 1.02 |
| Enterprise/Revenue | 0.9 |
| Enterprise/EBITDA | 15.34 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0.02 |
| Operating Margin | 0.01 |
| Return On Assets | 0.01 |
| Return On Equity | 0.02 |
| Revenue | 3.2B |
| Revenue/Share | 5.07 |
| Gross Profit | 666.98M |
| EBITDA | 231.62M |
| Net Income | 53.91M |
| Diluted EPS | 0.09 |
| Total Cash | 1.49B |
| Total Cash/Share | 2.39 |
| Total Debt | 226.68M |
| Total Debt/Equity | 0.06 |
| Current Ratio | 3.93 |
| Book Value Per Share | 7.8 |
| 52-Week Change | -6.61 |
| 52-Week High | 9.8 |
| 52-Week Low | 5.8 |
| Moving Average 50 Days | 6.88 |
| Moving Average 200 Days | 7.24 |
| Average Volume | 30.32M |
| Shares Outstanding | 621.92M |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 0.1 |
| Trailing Annual Dividend Yield | 1.61 |
| Payout Ratio | 0.98 |
| Last Split Factor | 3:2 |
| Last Split Date | July 10, 2006 |